While the minimum of 270K over may seem like a small figure when we compare it to revenue numbers of an established medtech company - this is great news. For those not in the know of how the Medtech industry operates - the first adopters will generally be these cutting edge academic hospitals, who will spread the good word / clinical data on new technology to other hospitals.
With Cleavland on board, it's only a matter of time until we get some significant traction in the rest of the market - this will be accelerated by the Phillips deal.
Ann: 3-year contract extension secured with the Cleveland Clinic, page-17
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
46.3¢ |
Change
0.068(17.1%) |
Mkt cap ! $214.1M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 48.5¢ | 38.0¢ | $2.136M | 4.738M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 25182 | 45.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 46.5¢ | 14614 | 6 |
View Market Depth
| Last trade - 13.27pm 07/08/2025 (20 minute delay) ? |
| 4DX (ASX) Chart |